All
Coherus Announces Lowest Price for Humira Biosimilar, Partners with Mark Cuban Cost Plus
June 2nd 2023Coherus will launch Yusimry in July with a list price of $995 per carton (2 x 40 mg/0.8 mL autoinjectors); “the lowest price announced to date of any adalimumab offering in the United States,” the company said.
New Heart Failure Med Will be Priced 'Competitively'
May 30th 2023Inpefa (sotagliflozin) is in the SGLT inhibitor class recommended as first-line treatment for heart failure by the American Heart Association and other groups. Jardiance (empaglifozin), a competitor in that class, has a list price of $570.48 for a month's supply.